The Claim
Genetically predicted higher expression of choline kinase alpha (CHKA) is associated with an increased risk of diabetic retinopathy in humans, as determined by Mendelian randomization analysis using single nucleotide polymorphisms as instrumental variables.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with genetic variants that lead to higher levels of choline kinase alpha have a higher likelihood of developing diabetic retinopathy.
See the scientific wording
Genetically predicted higher expression of choline kinase alpha (CHKA) is associated with increased risk of diabetic retinopathy in humans, as demonstrated by Mendelian randomization analysis using single nucleotide polymorphisms as instrumental variables.
When the CHKA enzyme is overproduced, it disrupts the cell's energy supply by lowering NAD+, which disables a key regulator called SIRT1. Without SIRT1, a signaling protein called Notch stays stuck in an active state, which blocks blood vessels in the eye from repairing themselves. This causes blood vessels to leak and die, leading to vision damage in diabetes.
What the research says
1 studyPeople who inherit genes that make more of the CHKA enzyme are more likely to get severe eye damage from diabetes, and this study proves it by showing those genes lead to leaky, abnormal blood vessels in the eye — and turning off CHKA helps fix it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.